Syngeneic tumor models, which varied in their intrinsic sensitivity to murine IFNα stimulation (S4 Fig) but lacked human or murine CD38 surface expression, were treated with mCD38-mAtt to interrogate the immune-directed activity of a CD38-targeted AttenukineTM in isolation. Here, CD38 is linked to neoplasm.